Back
Oracle Corp. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
38
ORCL
Oracle Corp.
Last Price:
$221.68
Seasonality Move:
12.46%
Buy
57
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$102.94
Seasonality Move:
-6.7%
Sell
38
Oracle Corp. (ORCL)
is a Sell
Is Oracle Corp. a Buy, Sell or Hold?
-
The current Oracle Corp. [ORCL] share price is $220.54. The Score for ORCL is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
ORCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Buy
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $105.18. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ORCL Stock Price Chart
What is Oracle Corp.'s stock price today?
-
The Oracle Corp. share price today is $220.54The current trend is relatively stagnant and ORCL is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $105.18The current trend is moderately bearish and RYTM is experiencing slight selling pressure.
ORCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -11.52 | Sell |
| Relative Strength Index (14 RSI): | 46.52 | Sell |
| Chaikin Money Flow: | -1828122 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (203.4 - 238.64) | Sell |
| Bollinger Bands (100): | (223.02 - 288.84) | Sell |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 51.73 | Buy |
| Chaikin Money Flow: | -33785 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (98.75 - 107.07) | Buy |
| Bollinger Bands (100): | (93.01 - 107.07) | Buy |
ORCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.64 | Buy |
| 20-day SMA: | 214.31 | Buy |
| 50-day SMA: | 253.36 | Sell |
| 200-day SMA: | 212.14 | Buy |
| 8-day EMA: | 212.19 | Buy |
| 20-day EMA: | 219.05 | Buy |
| 50-day EMA: | 238.6 | Sell |
| 200-day EMA: | 222.49 | Sell |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 105.38 | Sell |
| 20-day SMA: | 102.79 | Buy |
| 50-day SMA: | 104.38 | Buy |
| 200-day SMA: | 80.61 | Buy |
| 8-day EMA: | 104.86 | Buy |
| 20-day EMA: | 104.36 | Buy |
| 50-day EMA: | 102.98 | Buy |
| 200-day EMA: | 85.73 | Buy |
Oracle Corp. Earnings Growth & ORCL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.82 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.66 per share.
Oracle Corp. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||